Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-98.42	54.98	3480.32
Graham Fair Price	-25.33	750.72	1005.35
PEG	-144.03	-0.89	-0.36
Price/Book	-0.99	0.23	0.24
Price/Cash Flow	206.77	-72.59	23.66
Prices/Earnings	75.27	39.53	22.55
Price/Sales	26.21	0.95	0.76
Price/FCF	206.77	-72.59	23.66
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	27.89	0.11	0.08
Operating Margin	6931.45	0.02	< 0.005
ROA	-46.31	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-43.51
ROIC	< 0.005	< 0.005	10492.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.72	< 0.005	7212.40
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.99	53.71	5313.80
EPS QOQ	-0.62	-0.44	28.17
FCF QOQ	0.16	-1.32	742.78
Revenue QOQ	0.27	-0.22	-19.25
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	31.86	39.91	25.26
Days Sales Outstanding (DSO)	97.55	109.14	11.87
Inventory Turnover	2.82	2.25	-20.16
Debt/Capitalization	0.12	0.19	62.25
Quick Ratio	1.38	0.84	-38.94
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4134.66	4108.00	-0.64
Cash	622.20	267.23	-57.05
Capex	-13.07	-6.02	53.94
Free Cash Flow	41.41	-13.28	-67.93
Revenue	1296.67	1010.61	-22.06
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.69	1.09	-35.25
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	199.59	26.19	-86.88
Naive Interpretation	Member

06 - Financial Health · Bad

Rating